Login
$ORMP
$4.08 -$0.05 (1.21%) Close

Interim Condensed Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Nov 30, 2021
Q3 FY2021
As of Aug 31, 2021
CURRENT ASSETS:
Cash and cash equivalents
Short-term deposits
Marketable securities
Investments at fair value
Convertible note
Related parties receivable
Prepaid expenses and other current assets
Total current assets
LONG-TERM ASSETS:
Long-term investments
Deposits
Marketable securities
Non-marketable equity securities
Other non-marketable equity securities (note 5)
Investments at fair value
Advance payments for real estate
Equity method investee
Investment in associates at fair value
Loan to an equity method investee
Investment in real estate (note 5)
Investment in Lifeward
Investment in real estate
Other non-marketable equity securities
Amounts funded in respect of employee rights upon retirement
Property and equipment, net
Operating lease right-of-use assets
Total long-term assets
Total assets
CURRENT LIABILITIES:
Accounts payable and accrued expenses
Short-term borrowings (note 7)
Payable to related parties
Related Parties
Total payable to related parties
Deferred income (note 8)
Deferred income
Dividend Payable
Operating lease liabilities
Total current liabilities
LONG-TERM LIABILITIES:
Long-term deferred revenues
Deferred revenues
Provision for uncertain tax position
Long-term deferred income (note 8)
Deferred income
Employee rights upon retirement
Provision for uncertain tax position (note 12f)
Operating lease liabilities
Dividend Payable
Other liabilities
Deferred tax liabilities
Total long-term liabilities
STOCKHOLDERS’ EQUITY:
Common stock, $0.012 par value (60,000,000 authorized shares; 41,314,211 and 39,275,006 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively)
Additional paid-in capital
Accumulated deficit
Non-controlling interests
Total stockholders’ equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support